Keywords: appointment, astrazeneca, glenn, gormley, joined, merck, co

Appointment at AstraZeneca

Article | 05 October 2000

Print This

Glenn Gormley has joined AstraZeneca from Merck & Co to become vicepresident of clinical development for the USA.

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in